Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Prostate Cancer Recurrent × Metformin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1 Genitourinary 1

Conditions

Polycystic Ovary Syndrome 124 Breast Neoplasms 36 Prostatic Neoplasms 29 Insulin Resistance 27 Obesity 18 Pancreatic Neoplasms 14 Neoplasms 13 Endometrial Neoplasms 13 Infertility 12 Colorectal Neoplasms 12 Carcinoma, Non-Small-Cell Lung 11 Anovulation 10 Lung Neoplasms 8 Neoplasm Metastasis 7 Metabolic Syndrome 7 Hyperandrogenism 7 Glioblastoma 7 Squamous Cell Carcinoma of Head and Neck 6 Melanoma 6 Lymphoma, Large B-Cell, Diffuse 5 Diabetes Mellitus 5 Adenocarcinoma 5 Weight Loss 4 Rectal Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Ovarian Neoplasms 4 Mouth Neoplasms 4 Head and Neck Neoplasms 4 Diabetes Mellitus, Type 2 4 Carcinoma, Ovarian Epithelial 4

Interventions

tempol 1 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1 TEMPOL-H 1 Sirolimus 1 Nelfinavir 1 Metformin 1 Hydroxychloroquine 1 Diet, Protein-Restricted 1 Dasatinib 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05036226 2025-10-06

COAST

Medical University of South Carolina

Phase 1/2 Recruiting

GenitourinaryOther solid neoplasm

Prostate Cancer Recurrent

Data powered by HemOnc (CC BY 4.0) Colophon ⚡